Can patients with low‐risk prostate cancer really benefit from radical treatment?: A systematic review and network meta‐analysis-Reference-Cited by-同舟云学术

Can patients with low‐risk prostate cancer really benefit from radical treatment?: A systematic review and network meta‐analysis

Published:2021-07-28 Issue:9 Volume:53 Page:
ISSN:0303-4569
Container-title:Andrologia
language:en
Short-container-title:Andrologia

Author:

Zhen Liang¹^ORCID,Zhien Zhou¹,Shengmin Yang²,Hanzhong Li¹,Xingcheng Wu¹,Yi Zhou¹,Yi Qiao¹,Lin Ma¹,Yuliang Chen¹,Tianrui Feng¹,Weigang Yan¹

Affiliation:

1. Department of Urology Peking Union Medical College Hospital Peking Union Medical College Chinese Academy of Medical Sciences Dongcheng District, Beijing China

2. Key Laboratory of Endocrinology of National Health Commission Department of Endocrinology State Key Laboratory of Complex Severe and Rare Diseases Peking Union Medical College Hospital Chinese Academy of Medical Science and Peking Union Medical College Beijing China

Publisher

Wiley

Subject

Urology,Endocrinology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/and.14122

Reference50 articles.

1. Second Primary Cancer After Radiotherapy for Prostate Cancer—A SEER Analysis of Brachytherapy Versus External Beam Radiotherapy

2. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population-based analysis

3. Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma

4. 13-Year Outcomes Following Treatment for Clinically Localized Prostate Cancer in a Population Based Cohort

5. Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment options for low-risk prostate cancer;World Journal of Urology;2022-09-13